Related Experiment Video
Updated: Mar 7, 2026

09:30
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
7.9K
Concentration-Normalized Electroanalytical Assaying of Exosomal Markers
Qian Li1, George K Tofaris2, Jason J Davis1
1Department of Chemistry, Physical and Theoretical Chemistry Laboratory, University of Oxford , South Parks Road, Oxford OX1 3QZ, United Kingdom.
Analytical Chemistry
|February 15, 2017
Summary
This study introduces ultrasensitive electrochemical impedance spectroscopy to quantify exosome markers. This method improves exosome biomarker analysis, overcoming previous sample preparation and signal-to-noise limitations for clinical applications.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Nanotechnology
Background:
- Exosomes mediate intercellular communication and carry disease biomarkers.
- Accurate exosome marker evaluation is crucial for clinical analysis but hindered by sample prep and signal issues.
- Current methods lack sensitivity and robustness for reliable exosome quantification.
Purpose of the Study:
- To develop a novel ultrasensitive method for quantifying exosome-specific markers.
- To overcome limitations in sample preparation and assay signal-to-noise ratio for exosome analysis.
- To enable robust dual-marker quantification for improved clinical diagnostics.
Main Methods:
- Utilized ultrasensitive electrochemical impedance spectroscopy (EIS).
- Quantified both external (tetraspanin) and internal (syntenin) exosome markers.
- Employed simple fine filtering for sample preparation, avoiding nanoparticle tracking analysis (NTA) for concentration determination.
Main Results:
- Achieved exosome detection limits of 1.9 × 10^5 particles mL^-1.
- Quantified internal syntenin levels with 3-5 picomolar sensitivity and a 5-decade linear dynamic range.
- Developed a concentration-normalized dual-marker analysis independent of absolute exosome concentration.
Conclusions:
- Ultrasensitive EIS provides a robust platform for exosome marker quantification.
- The method overcomes key challenges in exosome analysis, enabling potential clinical translation.
- Concentration-normalized dual-marker analysis offers reliable diagnostic zones irrespective of sample variations.

